|
|
|
«
1-A
B
C-D
E-G
H-L
M
N-O
P
Q-R
S
T-U
V-Z
»
«
Salix
Shalo »
|
 |
|
|
Salix Ventures
Offices: Andover, Massachusetts; Nashville,
Tennessee & San Francisco, California
Salix invests exclusively in health care
services and health care information technology
companies. They are stage-agnostic, investing
in companies seeking their first round of
institutional venture capital as well as
more mature companies seeking later-stage
rounds. They do not make seed-stage investments,
requiring that the companies in which they
invest have some operational base already
in place in an industry with a demonstrated
proof of concept. Salix prefers investment
opportunities that already have the CEO
on board who is capable of guiding the company
through liquidity. |
Sanderling Biomedical Venture Capital
Offices: San Diego-San Mateo, California
Founded in 1979, Sanderling is among the
oldest investment firms dedicated to building
new biomedical companies. Sanderling demonstrates
that significant companies are best built
in close working partnerships with entrepreneurs.
Sanderling's unique approach combines a
specialized investment focus with active
management and long-term commitment to ensure
the highest rates-of-return for both its
entrepreneurs and investors. Since its inception,
Sanderling has supported over 40 biomedical
companies from very early stages through
commercial development, earning consistently
high rates-of-return on its venture investments. |
Sante Ventures
Offices: Austin, Texas
Welcome to Sante, a new venture capital
firm with deep healthcare investment experience.
Their founding premise is simple: they partner
with exceptional entrepreneurs and executives
to build uncommonly valuable healthcare
companies. In addition to capital, they
provide healthcare domain expertise, an
extensive network of contacts and singular
industry focus. Sante invests exclusively
in early-stage medical technology, healthcare
services and healthcare IT companies. |
SCP Vitalife
Offices: Wayne, Pennsylvania & Tel Aviv,
Israel
SCP Vitalife seeks to invest in early- to
mid-stage stage life science companies with
exceptional technology or other proprietary
advantages that are poised to capitalize
on major market trends. Over half of the
Fund's investment capital is expected to
go to Israeli companies with the remainder
allocated to US companies. Their target
initial investment size is $3 - $7 million,
with typical total investment of $7-$15
million over the lifespan of the investment. |
|
|
Seaflower Ventures
Offices: Waltham, Massachusetts
Seaflower Ventures is a life science focused
venture capital firm formed by entrepreneurs
from the biopharmaceutical industry to provide
capital, advice, and hands-on support to
promising life science and medical technology
start-ups. Seaflower Ventures was founded
in 1993 on the premise that successful life
science investing requires substantial prior
industry experience in senior operating
roles, in-depth scientific, medical, business
and financial expertise, a limited number
of portfolio companies per partner, and
hands-on support of portfolio companies. |
Sears Capital Management
Offices: Los Altos, California
Sears Capital Management is a venture investment
and portfolio management firm specializing
in the life sciences. Since its founding
in 1994, Sears Capital Management and its
affiliated funds have provided seed capital
and early stage financing for life science
companies and startups. Sears Capital Management's
target investment areas are pharmaceuticals,
suppliers to the pharmaceutical industry
and medical devices. In addition, Sears
Capital Management manages a portfolio of
publicly traded life science company stocks.
|
Seneca Partners
Offices: Detroit, Michigan & Chicago,
Illinois
Seneca Partners supports entrepreneurs by
drawing upon its experience as an advisor
and an investor to provide the guidance
and advice necessary to navigate the complexities
of middle-market mergers, acquisitions,
divestitures and other strategic transactions.
In addition, Seneca Partners assists firms
in securing senior debt, subordinated debt
and/or equity capital necessary to achieve
their vision. For select situations, Seneca
will provide growth capital directly through
Seneca Health Partners, a growth-stage venture
capital fund focused on healthcare.
|
Seroba BioVentures
Offices: Dublin, Ireland
Seroba BioVentures is a life science venture
capital management firm. Seroba was established
in 2001 as Ireland’s first fully dedicated
life science venture capital fund and is
now the leading life science investor in
Ireland. Seroba seeks to invest in the best
opportunities across the life sciences and
medical device sectors. Investments have
been made in specialty pharmaceuticals,
biotechnology, diagnostics and instrumentation
companies. |
| |
|
|
|
|
|
Bio Life (-Shalon-)
Resources
to
top